All Stories

  1. Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity

    Article • Current Cancer Drug Targets, April 2023, Bentham Science Publishers

    Mr. Vijay Kumar, Dr Vinod Kumar, Mr. Ravi Prakash Yadav, Vinay Kumar, Suraj Singh Rawat

  2. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease

    Article • Current Medicinal Chemistry, March 2022, Bentham Science Publishers

    Dr Vinod Kumar, Mr. Bhupinder Kumar

  3. Recent Synthetic Strategies for Monocyclic Azole Nucleus and Its Role in Drug Discovery and Development

    Article • Current Organic Synthesis, April 2018, Bentham Science Publishers

    Dr Vinod Kumar

  4. Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials

    Article • Current Cancer Drug Targets, April 2017, Bentham Science Publishers

    Mr. Bhupinder Kumar, Dr Vinod Kumar, Professor Ira Skvortsova

  5. Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy

    Article • Current Cancer Drug Targets, April 2017, Bentham Science Publishers

    Dr Anjana Munshi, Dr Vinod Kumar

  6. 1,2,4-Triazole Nucleus in Anticancer Compounds

    Article • Anti-Cancer Agents in Medicinal Chemistry, February 2016, Bentham Science Publishers

    Dr Vinod Kumar, Mr. Bhupinder Kumar